Abstract
Pathogenic free-living amoebae are known to cause fatal central nervous system infections with extremely high mortality rates. High selectivity of the blood–brain barrier hampers delivery of drugs and untargeted delivery of drugs can cause severe side effects. Nanovehicles can be used for targeted drug delivery across the blood–brain barrier. Inorganic nanoparticles have been explored as carriers for various biomedical applications and can be modified with various ligands for efficient targeting and cell selectivity while lipid-based nanoparticles have been extensively used in the development of both precision and colloidal nanovehicles. Nanomicelles and polymeric nanoparticles can also serve as nanocarriers and may be modified so that responsiveness of the nanoparticles and release of the loads are linked to specific stimuli. These nanoparticles are discussed here in the context of the treatment of central nervous system infections due to pathogenic amoebae. It is anticipated that these novel strategies can be utilized in tandem with novel drug leads currently in the pipeline and yield in the development of much needed treatments against these devastating parasites.
Similar content being viewed by others
Data availability
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Ethical approval and consent to participate.
This article does not contain any studies with human participants. This article does not contain any studies involving animals.
References
Abenojar EC, Wickramasinghe S, Bas-Concepcion J, Samia ACS (2016) Structural effects on the magnetic hyperthermia properties of iron oxide nanoparticles. Prog Nat Sci Mater Int 26(5):440–448
Aichelburg AC, Walochnik J, Assadian O, Prosch H, Steuer A, Perneczky G, Visvesvara GS, Aspöck H, Vetter N (2008) Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine. Emerg Infec Dis 14(11):1743
Anwar A, Masri A, Rao K, Rajendran K, Khan NA, Shah MR, Siddiqui R (2019a) Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids. Sci Rep 9(1):1–12
Anwar A, Mungroo MR, Anwar A, Sullivan WJ Jr, Khan NA, Siddiqui R (2019b) Repositioning of guanabenz in conjugation with gold and silver nanoparticles against pathogenic amoebae Acanthamoeba castellanii and Naegleria fowleri. ACS Infect Dis 5(12):2039–2046
Anwar A, Siddiqui R, Shah M, Khan N (2019c) Gold nanoparticles conjugation enhances antiacanthamoebic properties of nystatin, fluconazole and amphotericin B. J Microbiol Biotechnol 29:171–177
Anwar A, Siddiqui R, Shah M, Khan N (2019d) Gold nanoparticles conjugation enhances antiacanthamoebic properties of nystatin, fluconazole and amphotericin B. J Microbiol Biotechnol 29(1):171–177
Anwar A, Mungroo MR, Khan S, Fatima I, Rafique R, Khan KM, Siddiqui R, Khan NA (2020) Novel azoles as antiparasitic remedies against brain-eating amoebae. Antibiotics 9(4):188
Baig AM, Lalani S, Khan NA (2017) Apoptosis in Acanthamoeba castellanii belonging to the T4 genotype. J Basic Microbiol 57(7):574–579
Barani M, Mukhtar M, Rahdar A, Sargazi G, Thysiadou A, Kyzas GZ (2021) Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections. Molecules 26(1):186
Bergin IL, Wilding LA, Morishita M, Walacavage K, Ault AP, Axson JL, Stark DI, Hashway SA, Capracotta SS, Leroueil PR, Maynard AD (2016) Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model. Nanotoxicology 10(3):352–360
Burger RM, Franco RJ, Drlica K (1994) Killing acanthamoebae with polyaminopropyl biguanide: quantitation and kinetics. Antimicrob Agents Chemother 38(4):886–888
Chang D, Lim M, Goos JA, Qiao R, Ng YY, Mansfeld FM, Jackson M, Davis TP, Kavallaris M (2018) Biologically targeted magnetic hyperthermia: potential and limitations. Front Pharmacol 9:831
Debnath A, Tunac JB, Galindo-Gómez S, Silva-Olivares A, Shibayama M, McKerrow JH (2012) Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen. Antimicrob Agents Chemother 56(11):5450–5457
Debnath A, Nelson AT, Silva-Olivares A, Shibayama M, Siegel D, McKerrow JH (2018) In vitro efficacy of ebselen and BAY 11–7082 against Naegleria fowleri. Front Microbiol 9:414
Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C (2019) Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf, B 183:110446
Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545–2561
Ertabaklar H, Türk M, Dayanir V, Ertuğ S, Walochnik J (2007) Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey. Parasitol Res 100(2):241–6
Gallardo-Toledo E, Velasco-Aguirre C, Kogan MJ (2021) Inorganic Nanoparticles and Their Strategies to Enhance Brain Drug Delivery. Nanomedicines for Brain Drug Delivery 157:149–172
García-Pinel B, Porras-Alcalá C, Ortega-Rodríguez A, Sarabia F, Prados J, Melguizo C, López-Romero JM (2019) Lipid-based nanoparticles: application and recent advances in cancer treatment. Nanomaterials 9(4):638
Garvey EP, Sharp AD, Warn PA, Yates CM, Schotzinger RJ (2018) The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis. J Antimicrob Chemother 73(10):2815–2822
Ghamkhari A, Sarvari R, Ghorbani M, Hamishehkar H (2018) Novel thermoresponsive star-liked nanomicelles for targeting of anticancer agent. Eur Polymer J 107:143–154
Hady MA, Sayed OM, Akl MA (2020) Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Colloids Surf, B 193:111076
Hendiger E, Padzik M, Sifaoui I, Reyes-Batlle M, López-Arencibia A, Rizo-Liendo A, Bethencourt-Estrella C, Nicolás-Hernández DS, Chiboub O, Rodríguez-Expósito RL, Grodzik M (2020) Silver nanoparticles as a novel potential preventive agent against Acanthamoeba keratitis. Pathogens 9(5):350
Heredero-Bermejo I, Copa-Patiño JL, Soliveri J, García-Gallego S, Rasines B, Gómez R, De la Mata FJ, Pérez-Serrano J (2013) In vitro evaluation of the effectiveness of new water-stable cationic carbosilane dendrimers against Acanthamoeba castellanii UAH-T17c3 trophozoites. Parasitol Res 112(3):961–969
Heredero-Bermejo I, Sanchez-Nieves J, Soliveri J, Gomez R, De la Mata FJ, Copa-Patino JL, Perez-Serrano J (2016) In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms. Int J Pharm 509(1–2):1–7
Heredero-Bermejo I, Martín-Pérez T, Copa-Patiño JL, Gómez R, de la Mata FJ, Soliveri J, Pérez-Serrano J (2020) Ultrastructural study of Acanthamoeba polyphaga trophozoites and cysts treated in vitro with cationic carbosilane dendrimers. Pharmaceutics 12(6):565
Hong W, Zhang Z, Liu L, Zhao Y, Zhang D, Liu M (2018) Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and-resistant Pneumococcal meningitis: Formulated with RVG29 and Pluronic® P85 unimers. Drug Delivery 25(1):1886–1897
Iwata K, Ohnishi T, Ohishi H, Nozu K (1989) Hyperthermic effects on cell killing in Dictyostelium discoideum amoebae treated with DNA-damaging agents. Int J Hyperth 5(4):535–542
Jaiswal P, Gidwani B, Vyas A (2016) Nanostructured lipid carriers and their current application in targeted drug delivery. Artificial Cells, Nanomedicine, and Biotechnology 44(1):27–40
Kasra KR, Hojati V, Shiravi A (2015) Zinc oxide nanoparticles absorption rate in the heart tissue of female mice. J Chem Health Risks 5(3):193–198
Kaur P, Aliru ML, Chadha AS, Asea A, Krishnan S (2016) Hyperthermia using nanoparticles–promises and pitfalls. Int J Hyperth 32(1):76–88
Khalid M, El-Sawy HS (2017) Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm 528(1–2):675–691
Kunjachan S, Ehling J, Storm G, Kiessling F, Lammers T (2015) Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects. Chem Rev 115(19):10907–10937
Lakhundi S, Khan NA, Siddiqui R (2014) Inefficacy of marketed contact lens disinfection solutions against keratitis-causing Acanthamoeba castellanii belonging to the T4 genotype. Exp Parasitol 141:122–128
Lam C, Jamerson M, Cabral G, Carlesso AM, Marciano-Cabral F (2017) Expression of matrix metalloproteinases in Naegleria fowleri and their role in invasion of the central nervous system. Microbiology 163(10):1436–1444
Lorenzo-Morales J, Martínez-Carretero E, Batista N, Álvarez-Marín J, Bahaya Y, Walochnik J, Valladares B (2007) Early diagnosis of amoebic keratitis due to a mixed infection with Acanthamoeba and Hartmannella. Parasitol Res 102(1):167–169
Lorenzo-Morales J, Khan NA, Walochnik J (2015) An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite 22:10
Maciver SK, Piñero JE, Lorenzo-Morales J (2020) Is Naegleria fowleri an emerging parasite? Trends Parasitol 36(1):19–28
Mahmoodzadeh F, Jannat B, Ghorbani M (2019) Chitosan-based nanomicelle as a novel platform for targeted delivery of methotrexate. Int J Biol Macromol 126:517–524
Martinez AJ, Visvesvara GS (1997) Free-living, amphizoic and opportunistic amebas. Brain Pathol 7(1):583–598
Mohamed S, Parayath NN, Taurin S, Greish K (2014) Polymeric nano-micelles: versatile platform for targeted delivery in cancer. Ther Deliv 5(10):1101–1121
Mungroo MR, Anwar A, Khan NA, Siddiqui R (2019) Brain-eating amoebae infection: Challenges and opportunities in chemotherapy. Mini Rev Med Chem 19(12):980–987
Mungroo MR, Anwar A, Ali F, Khan S, Abdullah MA, Siddiqui R, Khan KM, Khan NA (2020) Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae. Exp Parasitol 218:107979
Mungroo MR, Shahbaz MS, Anwar A, Saad SM, Khan KM, Khan NA, Siddiqui R (2020a) Aryl quinazolinone derivatives as novel therapeutic agents against brain-eating amoebae. ACS Chem Neurosci 11(16):2438–2449
Mungroo MR, Anwar A, Khan NA, Siddiqui R (2020b) Gold-conjugated curcumin as a novel therapeutic agent against brain-eating amoebae. ACS Omega 5(21):12467–12475
Mungroo MR, Khan NA, Siddiqui R (2020c) Novel coronavirus: current understanding of clinical features, diagnosis, pathogenesis, and treatment options. Pathogens 9(4):297
Mungroo MR, Tong T, Khan NA, Anuar TS, Maciver SK, Siddiqui R (2021) Development of anti-acanthamoebic approaches. Int Microbiol 24(3):363–371
Mydin RBS, Moshawih S (2019) Nanoparticles in nanomedicine application: lipid-based nanoparticles and their safety concerns. Nanotechnology: Applications in Energy, Drug and Food. Springer, Cham, pp 227–232
Nagington J, Richards JE (1976) Chemotherapeutic compounds and Acanthamoebae from eye infections. J Clin Pathol 29(7):648–651
Naseri N, Valizadeh H, Zakeri-Milani P (2015) Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull 5(3):305
Neerooa BNHM, Ooi LT, Shameli K, Dahlan NA, Islam JMM, Pushpamalar J, Teow SY (2021) Development of Polymer-Assisted Nanoparticles and Nanogels for Cancer Therapy: An Update. Gels 7(2):60
Ong TYY, Khan NA, Siddiqui R (2017) Brain-eating amoebae: predilection sites in the brain and disease outcome. J Clin Microbiol 55(7):1989–1997
Ortega MÁ, Guzmán Merino A, Fraile-Martínez O, Recio-Ruiz J, Pekarek L, Guijarro GL, García-Honduvilla N, Álvarez-Mon M, Buján J, García-Gallego S (2020) Dendrimers and dendritic materials: From laboratory to medical practice in infectious diseases. Pharmaceutics 12(9):874
Pardeike J, Hommoss A, Müller RH (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366(1–2):170–184
Parhi P, Mohanty C, Sahoo SK (2012) Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today 17(17–18):1044–1052
Patel T, Zhou J, Piepmeier JM, Saltzman WM (2012) Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64(7):701–705
Persano F, Leporatti S (2020) Current Overview of inorganic nanoparticles for the treatment of central nervous system (CNS) diseases. Current Nanomaterials 5(2):92–110
Rahimnia R, Salehi Z, Ardestani MS, Doosthoseini H (2019) SPION conjugated curcumin nano-imaging probe: Synthesis and bio-physical evaluation. Iran J Pharm Res IJPR 18(1):183
Rajabi M, Mousa AS (2016) Lipid nanoparticles and their application in nanomedicine. Curr Pharm Biotechnol 17(8):662–672
Rajendran K, Anwar A, Khan NA, Siddiqui R (2017) Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri. ACS Chem Neurosci 8(12):2626–2630
Rajendran K, Anwar A, Khan NA, Aslam Z, Raza Shah M, Siddiqui R (2019) Oleic acid coated silver nanoparticles showed better in vitro amoebicidal effects against Naegleria fowleri than amphotericin B. ACS Chem Neurosci 11(16):2431–2437
Rice CA, Troth EV, Russell A, Kyle DE (2020) Discovery of anti-amoebic inhibitors from screening the MMV pandemic response box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii. Pathogens 9(6):476
Rinaldi F, Oliva A, Sabatino M, Imbriano A, Hanieh PN, Garzoli S, Mastroianni CM, De Angelis M, Miele MC, Arnaut M, Di Timoteo F (2020) Antimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery. Pharmaceutics 12(7):678
Sánchez-López E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, Cano A, Espina M, Ettcheto M, Camins A, Silva AM (2020) Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials 10(2):292
Schuster FL, Visvesvara GS (2004) Opportunistic amoebae: challenges in prophylaxis and treatment. Drug Resist Updates 7(1):41–51
Shao K, Zhang Y, Ding N, Huang S, Wu J, Li J, Yang C, Leng Q, Ye L, Lou J, Zhu L (2015) Functionalized Nanoscale Micelles with Brain Targeting Ability and Intercellular Microenvironment Biosensitivity for Anti-Intracranial Infection Applications. Adv Healthcare Mater 4(2):291–300
Sharma G, Kalra SK, Tejan N, Ghoshal U (2020) Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect. Exp Parasitol 218:108008
Shinde RL, Bharkad GP, Devarajan PV (2015) Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid. Eur J Pharm Biopharm 96:363–379
Siddiqui R, Khan NA (2012) Biology and pathogenesis of Acanthamoeba. Parasit Vectors 5(1):1–13
Siddiqui R, Khan NA (2015) Balamuthia mandrillaris: morphology, biology, and virulence. Tropical Parasitology 5(1):15
Siddiqui R, Khan NA (2020a) Current strategies to treat Acanthamoeba keratitis: a patent overview. Pharm Pat Anal 9(4):125–127
Siddiqui R, Khan NA (2020b) Current treatment options of emopenBalamuthia mandrillarisemclose: a patent overview. Pharm Pat Anal 9(4):121–123
Siddiqui R, Khan NA (2020c) War on Terror Cells: Strategies to Eradicate “Novel Coronavirus” Effectively. ACS Chem Neurosci 11(9):1198–1199
Siddiqui R, Syed A, Tomas S, Prieto-Garcia J, Khan NA (2009) Effect of free versus liposomal-complexed pentamidine isethionate on biological characteristics of Acanthamoeba castellanii in vitro. J Med Microbiol 58(3):327–330
Siddiqui R, Ali IKM, Cope JR, Khan NA (2016) Biology and pathogenesis of Naegleria fowleri. Acta Trop 164:375–394
Siddiqui R, Makhlouf Z, Khan NA (2021) The Increasing Importance of Vermamoeba vermiformis. J Eukaryot Microbiol e12857. https://doi.org/10.1111/jeu.12857
Stewart ER, Eldridge ML, McHardy I, Cohen SH, Thompson GR (2018) Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis. Mycopathologia 183(3):619–622
Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A (2013) Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol 19:29–43
Tang X, Liang Y, Zhu Y, Xie C, Yao A, Chen L, Jiang Q, Liu T, Wang X, Qian Y, Wei J (2015) Anti-transferrin receptor-modified amphotericin B-loaded PLA–PEG nanoparticles cure Candidal meningitis and reduce drug toxicity. Int J Nanomed 10:6227
Vaishya RD, Khurana V, Patel S, Mitra AK (2014) Controlled ocular drug delivery with nanomicelles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6(5):422–437
Visvesvara GS (2013) Infections with free-living amebae. Handb Clin Neurol 114:153–168
Walvekar S, Anwar A, Anwar A, Sridewi N, Khalid M, Yow YY, Khan NA (2020) Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba. Acta Trop 211:105618
Wang Q, Cheng S, Qin F, Fu A, Fu C (2021) Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system. RSC Adv 11(15):8505–8515
Wu Y, Xu Z, Sun W, Yang Y, Jin H, Qiu L, Chen J, Chen J (2019) Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment. Mater Sci Eng C 103:109831
Yingchoncharoen P, Kalinowski DS, Richardson DR (2016) Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev 68(3):701–787
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR (2020) Nanovehicles for co-delivery of anticancer agents. Drug Discovery Today 25(8):1416–1430
Zhang XD, Wu HY, Di Wu YYW, Chang JH, Zhai ZB, Meng AM, Liu PX, Zhang LA, Fan FY (2010) Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed 5:771
Zhang XF, Liu ZG, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci 17(9):1534
Zhang S, Asghar S, Yang L, Hu Z, Chen Z, Shao F, Xiao Y (2020) Borneol and poly (ethylene glycol) dual modified BSA nanoparticles as an itraconazole vehicle for brain targeting. Int J Pharm 575:119002
Zhou Q, Zhang L, Yang T, Wu H (2018) Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomed 13:2921
Acknowledgements
We are grateful to University of Sharjah, UAE for supporting this work.
Author information
Authors and Affiliations
Contributions
RS and NAK conceived the study amid discussion with MRM, and AA. MRM conducted literature search under the supervision of RS and NAK. MRM and RS prepared the first draft. NAK and AA corrected the manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mungroo, M.R., Khan, N.A., Anwar, A. et al. Nanovehicles in the improved treatment of infections due to brain-eating amoebae. Int Microbiol 25, 225–235 (2022). https://doi.org/10.1007/s10123-021-00201-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10123-021-00201-0